ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2017. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,702,000 | -26.4% | 940,400 | +576.8% | 0.68% | -51.4% |
| Q4 2018 | $6,392,000 | +43.5% | 138,958 | +38.4% | 1.41% | +146.7% |
| Q3 2018 | $4,453,000 | -23.6% | 100,369 | -32.5% | 0.57% | -36.7% |
| Q2 2018 | $5,828,000 | +114.1% | 148,704 | +295.0% | 0.90% | +455.6% |
| Q1 2018 | $2,722,000 | -70.9% | 37,646 | -73.5% | 0.16% | -81.0% |
| Q4 2017 | $9,361,000 | +124.1% | 142,185 | +70.6% | 0.85% | +212.5% |
| Q3 2017 | $4,178,000 | +887.7% | 83,357 | +338.7% | 0.27% | +1087.0% |
| Q4 2015 | $423,000 | -25.3% | 19,000 | -20.8% | 0.02% | 0.0% |
| Q3 2015 | $566,000 | +22.2% | 23,990 | +379.8% | 0.02% | +21.1% |
| Q1 2015 | $463,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
| Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
| EMC Capital Management | 27,566 | $583,000 | 0.33% |
| WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
| Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
| Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |